<DOC>
	<DOC>NCT01075204</DOC>
	<brief_summary>The objective is to describe the time to recovery of symptoms (cough, mucus, fever, sore throat, and others), tolerability and compliance of treatment with clarithromycin once daily in patients with upper or lower respiratory tract infections in the routine clinical practice.</brief_summary>
	<brief_title>Clarithromycin Modified Release Observational Study for Evaluation of Treatment, Tolerability &amp; Recovery Time in Saudi &amp; Egyptian Clinical Settings (CLOSER)</brief_title>
	<detailed_description />
	<mesh_term>Respiratory Tract Infections</mesh_term>
	<mesh_term>Clarithromycin</mesh_term>
	<criteria>Adults, equal to or more than 18 years years of age Patients with respiratory tract infections, including any of the following: Acute tracheitis, acute tracheobronchitis Acute sinusitis Chronic sinusitis Acute tonsillopharyngitis Acute bronchitis Mild communityacquired pneumonia Acute exacerbation of chronic bronchitis Known hypersensitivity to or previously intolerant of macrolides. Illness severe enough to warrant hospitalization or parenteral therapy. Concomitant use of any of the following medications: Drugs metabolized by CYP3A isozyme: alprazolam, astemizole, carbamazepine, cilostazol, cisapride, cyclosporin, disopyramide, ergot alkaloids, lovastatin, methylprednisolone, midazolam, omeprazole, oral anticoagulants (e.g. warfarin), pimozide, quinidine, rifabutin, sildenafil, simvastatin, tacrolimus, terfenadine, triazolam and vinblastine. Drugs metabolized by other isozymes within CYP450 system: phenytoin, theophylline and valproate. Colchicine, Digoxin, Some antiretrovirals: zidovudine and ritonavir. Severe immunodeficiency and chronic disease conditions. Renal or hepatic impairment (creatinine clearance under 30 mL/min, aspartate aminotransferase (AST), alanine aminotransferase (ALT) and gammaglutamyltransferase (GGT) equal or more than 3x higher level in comparison with the norm). Mental condition rendering the subject unable to understand the nature of the study.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Respiratory Tract Infection</keyword>
	<keyword>Clarithromycin</keyword>
	<keyword>Recovery</keyword>
</DOC>